Devender Pathak

Devender Pathak

Auto-generated profile, based on publicly available information

Devender Pathak

Department of Pharmacology, Rajiv Academy for Pharmacy, Mathura, Uttar Pradesh, INDIA

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ASAshwani Sharma
Ashwani Sharma
TVTarun Virmani
Tarun Virmani
VPVipluv Pathak
Vipluv Pathak
ASAnjali Sharma
Anjali Sharma
KPKamla Pathak
Kamla Pathak
DPDevender Pathak
Devender Pathak
The global COVID‐19 (coronavirus disease 2019) pandemic, which was caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), has resulted in a significant loss of human life around the world. The SARS‐CoV‐2 has caused significant problems to medical systems and healthcare facilities due to its unexpected global expansion. Despite all of the efforts, developing effective treatments, diagnostic techniques, and vaccinations for this unique virus is a top priority and takes a long time. However, the foremost step in vaccine development is to identify possible antigens for a vaccine. The traditional method was time taking, but after the breakthrough technology of reverse vaccinology (RV) was introduced in 2000, it drastically lowers the time needed to detect antigens ranging from 5–15 years to 1–2 years. The different RV tools work based on machine learning (ML) and artificial intelligence (AI). Models based on AI and ML have shown promising solutions in accelerating the discovery and optimization of new antivirals or effective vaccine candidates. In the present scenario, AI has been extensively used for drug and vaccine research against SARS‐COV‐2 therapy discovery. This is more useful for the identification of potential existing drugs with inhibitory human coronavirus by using different datasets. The AI tools and computational approaches have led to speedy research and the development of a vaccine to fight against the coronavirus. Therefore, this paper suggests the role of artificial intelligence in the field of clinical trials of vaccines and clinical practices using different tools.

16 April 2018 in Mini-Reviews in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
SJShweta Jain
Shweta Jain
SPSatyanarayan Pattnaik
Satyanarayan Pattnaik
KPKamla Pathak
Kamla Pathak
SKSushant Kumar
Sushant Kumar
DPDevender Pathak
Devender Pathak
AVAnkur Vaidya
Ankur Vaidya
Thiazole nucleus is one of the most important and well-known heterocyclic nuclei that possesses almost all types of biological activities. Thiazole compounds play an important role in anticancer drug development as they have shown excellent results through different mechanism of action. A number of thiazole derivatives have been reported till date for their anticancer activity. The present review is complementary to earlier reviews and aims to review the work reported on the anticancer activity of thiazole derivatives from year 2000 to the beginning of 2016. Their mechanism of action and possible structure activity relationship has also been discussed.

1 December 2024 in Current Pharmaceutical Biotechnology
Verified
Journal Article
Closed access
PDF file
RPRam Narayan Prajapati
Ram Narayan Prajapati
BBBharat Bhushan
Bharat Bhushan
Kuldeep SinghKuldeep Singh
Kuldeep Singh
HCHimansu Chopra
Himansu Chopra
Shivendra KumarShivendra Kumar
Shivendra Kumar
LALaxmikant
Laxmikant
: Pharmaceutical design has made significant advancements in recent years, leading to the development of novel therapeutics with unprecedented efficacy and safety profiles. This review highlights the potential of these innovations to revolutionize healthcare and improve patient outcomes. The application of cutting-edge technologies like artificial intelligence, machine learning, and data mining in drug discovery and design has made it easier to find potential drug candidates. Combining big data and omics has led to the discovery of new therapeutic targets and personalized medicine strategies. Nanoparticles, liposomes, and microneedles are examples of advanced drug delivery systems that allow precise control over drug release, better bioavailability, and targeted delivery to specific tissues or cells. This improves the effectiveness of the treatment while reducing side effects. Stimuli-responsive materials and smart drug delivery systems enable drugs to be released on demand when specific internal or external signals are sent. Biologics and gene therapies are promising approaches in pharmaceutical design, offering high specificity and potency for treating various diseases like cancer, autoimmune disorders, and infectious diseases. Gene therapies hold tremendous potential for correcting genetic abnormalities, with recent breakthroughs demonstrating successful outcomes in inherited disorders and certain types of cancer. Advancements in nanotechnology and nanomedicine have paved the way for innovative diagnostic tools and therapeutics, such as nanoparticle-based imaging agents, targeted drug delivery systems, gene editing technologies, and regenerative medicine strategies. Finally, the review emphasizes the importance of regulatory considerations, ethical challenges, and future directions in pharmaceutical design. Regulatory agencies are adapting to the rapid advancements in the field, ensuring the safety and efficacy of novel therapeutics while fostering innovation. Ethical considerations regarding the use of emerging technologies, patient privacy, and access to advanced therapies also require careful attention.

1 June 2007 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Rajiv DahiyaRajiv Dahiya
Rajiv Dahiya
DPDevender Pathak
Devender Pathak

1 January 1996 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
RGR Gupta
R Gupta
DPD Pathak
D Pathak
DJDp Jindal
Dp Jindal

1 June 2024 in Pharmaceutical Nanotechnology
Verified
Journal Article
Closed access
PDF file
SSShivani Sharma
Shivani Sharma
AGAkash Garg
Akash Garg
RARutvi Agrawal
Rutvi Agrawal
HCHimansu Chopra
Himansu Chopra
DPDevender Pathak
Devender Pathak
Over the past few decades, advancements in nanocarrier-based therapeutic delivery have been significant, and niosomes research has recently received much interest. The self-assembled nonionic surfactant vesicles lead to the production of niosomes. The most recent nanocarriers, niosomes, are self-assembled vesicles made of nonionic surfactants with or without the proper quantities of cholesterol or other amphiphilic molecules. Because of their durability, low cost of components, largescale production, simple maintenance, and high entrapment efficiency, niosomes are being used more frequently. Additionally, they enhance pharmacokinetics, reduce toxicity, enhance the solubility of poorly water-soluble compounds, & increase bioavailability. One of the most crucial features of niosomes is their controlled release and targeted diffusion, which is utilized for treating cancer, infectious diseases, and other problems. In this review article, we have covered all the fundamental information about niosomes, including preparation techniques, niosomes types, factors influencing their formation, niosomes evaluation, applications, and administration routes, along with recent developments.